4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-026140
Chief Financial Officer acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamm John M. Chief Financial Officer | 2022-03-16 | Grant or award | +20,000 | $2.59 | $51,800 | 26,800 | D |
| Derivatives | |||||||
| Hamm John M. Chief Financial Officer | 2022-03-16 | Grant or award · Options (right to buy) | +2,000 | 2,000 | D | ||
Loading xslF345X03/doc4.xml…